Drug Discovery And Pharmaceuticals companies

Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.

We're biomedical researchers investing in a new generation of translational founders.

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

We are a venture studio leveraging Alloy’s pre-competitive drug discovery platforms. Established drug discovery, scientific, and lab resources allow entrepreneu…

Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. We iden…

Curie.Bio is a new model for venture capital in biotech. We are focused on a singular mission – helping founders launch therapeutics companies that go on to rai…

Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives.

We are long-term investors in engineering biology to treat - or better, cure - human disease.

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solution…

Identifying true innovations and building ambitious companies.

Danaher Ventures (DV) is a leading Ventures group in healthcare was formed to fuel the long term growth of Danaher’s Life Sciences and Diagnostics platforms thr…

At Third Rock, we push the boundaries of science and technology to make a difference in the lives of patients and their families.

Nurturing great biomed companies with Asia focus.

DigiTx Partners invests in and supports early to growth stage startup companies in the digital health space. We seek out innovative founders and leaders who are…

A venture capital firm uniquely dedicated to the frontier of neuroscience.

Mirae Asset believes in changing the future through investment.

Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade.

A £250m specialist venture capital fund that invests in, and creates, new biotech companies to deliver high impact therapeutics for age-related dementias.